84 related articles for article (PubMed ID: 12496979)
21. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention.
Mutaguchi K; Matsubara A; Kajiwara M; Hanada M; Mizoguchi H; Ohara S; Yasumoto H; Usui T
Urology; 2006 Aug; 68(2):307-11. PubMed ID: 16904442
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of benign prostatic hyperplasia by radiofrequency (TUNA): a monocentric study of 28 cases treated in ambulatory surgery].
Le Gal S; Fouques Y; Mallick S; Taksin L; Le Toquin-Bernard S; Frachet O; Bensadoun H
Prog Urol; 2009 May; 19(5):327-32. PubMed ID: 19393538
[TBL] [Abstract][Full Text] [Related]
23. A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes.
Bozlu M; Ulusoy E; Cayan S; Akbay E; Görür S; Akbay E
Scand J Urol Nephrol; 2004; 38(5):391-5. PubMed ID: 15764250
[TBL] [Abstract][Full Text] [Related]
24. Comparative early results of the sandwich technique and transurethral electroresection in benign prostatic hyperplasia.
Perk H; Serel TA; Koşar A; Hoşcan MB
Prostate Cancer Prostatic Dis; 2001; 4(4):242-244. PubMed ID: 12497026
[TBL] [Abstract][Full Text] [Related]
25. Transurethral RollerLoop vapor resection of prostate for treatment of symptomatic benign prostatic hyperplasia: a 2-year follow-up study.
Liu CK; Lee WK; Ko MC; Jeng HS; Chiang HS; Yu HJ
Scand J Urol Nephrol; 2006; 40(5):409-15. PubMed ID: 17060088
[TBL] [Abstract][Full Text] [Related]
26. Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon(R)) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
Al-Shukri SH; Deschaseaux P; Kuzmin IV; Amdiy RR
Prostate Cancer Prostatic Dis; 2000 Nov; 3(3):195-199. PubMed ID: 12497097
[TBL] [Abstract][Full Text] [Related]
27. Intraprostatic botulinum toxin type A injection for the treatment of benign prostatic hyperplasia: Initial experience with Dysport.
Nikoobakht M; Daneshpajooh A; Ahmadi H; Namdari F; Rezaeidanesh M; Amini S; Pourmand G
Scand J Urol Nephrol; 2010 Apr; 44(3):151-7. PubMed ID: 20201752
[TBL] [Abstract][Full Text] [Related]
28. [Benign prostatic hyperplasia: five year follow-up in patients who underwent contact laser vaporization].
Vela Navarrete R; García Cardoso JV; Calahorra Fernández FJ; Rodríguez Miñón JL; Cabrera Pérez J; González Enguita C
Arch Esp Urol; 2004 Mar; 57(2):131-4. PubMed ID: 15074782
[TBL] [Abstract][Full Text] [Related]
29. [Interstitial laser coagulation for benign prostatic hyperplasia: clinical results of the Indigo diode laser system].
Matsuta Y; Ichioka K; Terada N; Maekawa S; Okubo K; Yoshimura K; Terai A; Arai Y
Hinyokika Kiyo; 2003 Apr; 49(4):195-200. PubMed ID: 12784712
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of benign prostatic hyperplasia with the Revolix laser].
Mattioli S; Muñoz R; Recasens R; Berbegal C; Cortada J; Urmeneta JM; Teichmann H
Arch Esp Urol; 2008 Nov; 61(9):1037-43. PubMed ID: 19140585
[TBL] [Abstract][Full Text] [Related]
31. Relief by botulinum toxin of lower urinary tract symptoms owing to benign prostatic hyperplasia: early and long-term results.
Brisinda G; Cadeddu F; Vanella S; Mazzeo P; Marniga G; Maria G
Urology; 2009 Jan; 73(1):90-4. PubMed ID: 18995889
[TBL] [Abstract][Full Text] [Related]
32. Change in urinary symptoms and quality of life in men with benign prostatic hyperplasia after transurethral resection of prostate.
Chalise PR; Agrawal CS
Nepal Med Coll J; 2007 Dec; 9(4):255-8. PubMed ID: 18298015
[TBL] [Abstract][Full Text] [Related]
33. Change in International Prostate Symptom Score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally.
Tsukamoto T; Masumori N; Rahman M; Crane MM
Int J Urol; 2007 Apr; 14(4):321-4; discussion 325. PubMed ID: 17470162
[TBL] [Abstract][Full Text] [Related]
34. [Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia].
Xia SJ; Zhang YN; Lu J; Sun XW; Zhang J; Zhu YY; Li WG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3225-8. PubMed ID: 16405847
[TBL] [Abstract][Full Text] [Related]
35. [Effect of transurethral resection of prostate on quality of life in aged patients with benign prostatic hyperplasia].
Cheng NZ; Tang ZY; Liu Y; Liu XS; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 33(10):975-8. PubMed ID: 19001744
[TBL] [Abstract][Full Text] [Related]
36. [Fushile: a safe and effective therapeutic for benign prostatic hyperplasia].
Shang XJ; Liu ZY; Liu ZF; Sun YH; Huang YF
Zhonghua Nan Ke Xue; 2008 Mar; 14(3):227-30. PubMed ID: 18488335
[TBL] [Abstract][Full Text] [Related]
37. [Clinical effectiveness and safety study of combined therapy with an alpha-blocker and an anticholinergic for patients with LUT/BPH].
Xiao H; Li HZ; Yang Y; Huang ZM; Li YQ; Zhao XF
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1590-3. PubMed ID: 17803845
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of transurethral ethanol ablation of prostate for symptomatic benign prostatic hyperplasia.
Faruque MS; Alam MK; Ullah MA; Rahman MH; Kibria MG; Haque MM; Haque MA; Joarder AI; Paul BK
Mymensingh Med J; 2012 Apr; 21(2):265-9. PubMed ID: 22561769
[TBL] [Abstract][Full Text] [Related]
39. [Transurethral prostatectomy with the bipolar plasmakinetic technique for benign prostate hyperplasia: a report of 712 cases].
Che XY; Song XS; Wu DJ; Wang FP; Wang QF; Wang JB
Zhonghua Nan Ke Xue; 2009 May; 15(5):449-51. PubMed ID: 19514560
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM
BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
